These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30674687)

  • 121. Direct medical cost for surgical and medical treatment of condylomata acuminata.
    Kuwahara RT; Skinner RB; Tyring SK
    Arch Dermatol; 2002 Apr; 138(4):533; author reply 533-4. PubMed ID: 11939820
    [No Abstract]   [Full Text] [Related]  

  • 122. Genital warts and cost of care in England.
    Desai S; Wetten S; Woodhall SC; Peters L; Hughes G; Soldan K
    Sex Transm Infect; 2011 Oct; 87(6):464-8. PubMed ID: 21813567
    [TBL] [Abstract][Full Text] [Related]  

  • 123. The burden of HPV-related diseases in Italy, 2001-12.
    Kuhdari P; Previato S; Giordani M; Biavati P; Ferretti S; Gabutti G
    J Public Health (Oxf); 2017 Dec; 39(4):730-737. PubMed ID: 28334854
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Economic and humanistic burden of external genital warts.
    Raymakers AJ; Sadatsafavi M; Marra F; Marra CA
    Pharmacoeconomics; 2012 Jan; 30(1):1-16. PubMed ID: 22201520
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Epidemiology of human papillomavirus-associated anogenital cancers in Granada: a three-decade population-based study.
    Dabán-López P; Fernández-Martínez NF; Petrova D; Rodríguez-Barranco M; Jiménez-Moleón JJ; Gutierrez J; Sánchez MJ
    Front Public Health; 2023; 11():1205170. PubMed ID: 37780447
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Cost of treating recurrent respiratory papillomavirus in commercially insured and medicaid patients.
    Tam S; Wu CF; Peng HL; Dahlstrom KR; Sturgis EM; Lairson DR
    Laryngoscope; 2020 May; 130(5):1186-1194. PubMed ID: 31194270
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Structured Literature Review to Identify Human Papillomavirus's Natural History Parameters for Dynamic Population Models of Vaccine Impacts.
    Diakite I; Martins B; Owusu-Edusei K; Palmer C; Patterson-Lomba O; Gomez-Lievano A; Zion A; Simpson R; Daniels V; Elbasha E
    Infect Dis Ther; 2024 May; 13(5):965-990. PubMed ID: 38589763
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Use of human papillomavirus vaccine in HIV-infected men for the prevention of anal dysplasia and cancer.
    Cachay ER; Mathews WC
    AIDS Rev; 2014; 16(2):90-100. PubMed ID: 24818632
    [TBL] [Abstract][Full Text] [Related]  

  • 129. The indirect costs of human papillomavirus-related cancer in Central and Eastern Europe: years of life lost and productivity costs.
    Sabale U; Karamousouli E; Popovic L; Krasznai ZT; Harrop D; Meiwald A; Hughes R; Weston G; Bencina G
    J Med Econ; 2024 Apr; 27(sup2):1-8. PubMed ID: 38638098
    [TBL] [Abstract][Full Text] [Related]  

  • 130. A Few More Reasons to Vaccinate Against Human Papillomavirus: The Vulva and Vagina.
    Feldman S
    Obstet Gynecol; 2018 Aug; 132(2):259-260. PubMed ID: 29995721
    [No Abstract]   [Full Text] [Related]  

  • 131. Genital warts.
    Oriel JD
    Sex Transm Dis; 1977; 4(4):153-9. PubMed ID: 594860
    [No Abstract]   [Full Text] [Related]  

  • 132. Familial Clustering, Second Primary Cancers and Causes of Death in Penile, Vulvar and Vaginal Cancers.
    Zhang L; Hemminki O; Chen T; Zheng G; Försti A; Sundquist K; Sundquist J; Hemminki K
    Sci Rep; 2019 Aug; 9(1):11804. PubMed ID: 31413311
    [TBL] [Abstract][Full Text] [Related]  

  • 133. European guideline for the management of anogenital warts.
    von Krogh G; Lacey CJ; Gross G; Barrasso R; Schneider A; ;
    Int J STD AIDS; 2001 Oct; 12 Suppl 3():40-7. PubMed ID: 11589796
    [No Abstract]   [Full Text] [Related]  

  • 134. The Lifetime Cost Estimation of Human Papillomavirus-related Diseases in China: A Modeling Study.
    Ding W; Ma Y; Ma C; Malone DC; Ma A; Tang W; Si L
    J Transl Int Med; 2021 Sep; 9(3):200-211. PubMed ID: 34900631
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Therapeutic Use of the Human Papillomavirus Vaccine on Recurrent Respiratory Papillomatosis: A Systematic Review and Meta-Analysis.
    Rosenberg T; Philipsen BB; Mehlum CS; Dyrvig AK; Wehberg S; Chirilǎ M; Godballe C
    J Infect Dis; 2019 Mar; 219(7):1016-1025. PubMed ID: 30358875
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Should male circumcision be advocated for genital cancer prevention?
    Morris BJ; Mindel A; Tobian AA; Hankins CA; Gray RH; Bailey RC; Bosch X; Wodak AD
    Asian Pac J Cancer Prev; 2012; 13(9):4839-42. PubMed ID: 23167429
    [TBL] [Abstract][Full Text] [Related]  

  • 137. A retrospective analysis of the costs and management of genital warts in Italy.
    Gianino MM; Delmonte S; Lovato E; Martinese M; Rondoletti S; Bernengo MG; Zotti CM
    BMC Infect Dis; 2013 Oct; 13():470. PubMed ID: 24106891
    [TBL] [Abstract][Full Text] [Related]  

  • 138. HPV-related diseases in male patients: an underestimated conundrum.
    Garolla A; Graziani A; Grande G; Ortolani C; Ferlin A
    J Endocrinol Invest; 2024 Feb; 47(2):261-274. PubMed ID: 37770654
    [TBL] [Abstract][Full Text] [Related]  

  • 139. The role of circulating viral and tumour DNA in the diagnosis and management of HPV associated anogenital cancers, a systematic review and meta-analysis.
    Elasifer H; Amukwaya MMN; Bhatia R; Cuschieri K; Gregory JM
    J Clin Virol; 2023 Jul; 164():105469. PubMed ID: 37163963
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Estimating health state utility from activities of daily living in the French National Hospital Discharge Database: a feasibility study with head and neck cancer.
    Schwarzinger M; Luchini S;
    Health Qual Life Outcomes; 2019 Jul; 17(1):129. PubMed ID: 31345227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.